Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

STO/MCOV.B stock hub

STO/MCOV.B has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/MCOV.Bis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

30.6B

Nasdaq Stockholm

Market data

Live price

Current market quote for this ticker.

Current price

STO/MCOV.B

In the news

Latest news · STO/MCOV.B

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E26.2

P25 14.9P50 22.5P75 31.5

Trailing P/E35.2

P25 17.3P50 29.9P75 44.5

ROE13.9

P25 -86.1P50 -28.3P75 4.6

ROIC6.5

P25 -52.4P50 -16.9P75 5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/MCOV.B market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

236

Groups with data

Currency

EUR

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	49,000
Employees Change	-409%
Employees Change Percent	-0.83
Enterprise value	SEK 45.5B
Exchange	Nasdaq Stockholm
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	SE0009778848
Last refreshed	2026-05-10
Market cap	SEK 30.6B
Price	SEK 203
Price currency	SEK
Rev Per Employee	542,865.37x
Sector	Healthcare
Sic	8000
Symbol	sto/MCOV.B
Website	https://www.medicover.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.85%
EV Earnings	52.16x
EV/EBIT	24.74x
EV/EBITDA	11.25x
EV/FCF	23.98x
EV/Sales	1.71x
FCF yield	6.19%
Forward P/E	26.25x
P/B ratio	4.94x
P/E ratio	35.17x
P/S ratio	1.15x
PE Ratio10 Y	132.92x
PE Ratio3 Y	124.34x
PE Ratio5 Y	173.76x
PEG ratio	0.87x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.91%
EBITDA Margin	11.14%
FCF margin	7.13%
Gross margin	23.31%
Gross Profit	SEK 6.2B
Gross Profit Growth	18.64%
Gross Profit Growth Q	10.93%
Gross Profit Growth3 Y	19.36%
Gross Profit Growth5 Y	13.41%
Net Income	SEK 872.3M
Net Income Growth	159.8%
Net Income Growth Q	9.95%
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Net Income Growth3 Y	284.37%
Net Income Growth5 Y	8.69%
Pretax Margin	4.16%
Profit Margin	3.28%
Profit Per Employee	SEK 17,803
Profitable Years	12
ROA	4.55
Roa5y	3.76
ROCE	9.65
ROE	13.86
Roe5y	8.69
ROIC	6.51
Roic5y	6.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-14.9%
Cagr3y	3.83%
Cagr5y	-2.06%
Div CAGR3	16.9%
EPS Growth	158
EPS Growth Q	9.77
EPS Growth Quarters	5
EPS Growth Years	1
EPS Growth3 Y	283.2
EPS Growth5 Y	7.88
FCF Growth	16.59%
FCF Growth Q	-21.38%
FCF Growth3 Y	59.14%
FCF Growth5 Y	10.77%
OCF Growth	21.41%
OCF Growth Q	-16.91%
OCF Growth10 Y	49.73%
OCF Growth3 Y	20.97%
OCF Growth5 Y	13.3%
Revenue Growth	11.66x
Revenue Growth Q	7.97x
Revenue Growth Quarters	23x
Revenue Growth Years	11x
Revenue Growth3 Y	16.13x
Revenue Growth5 Y	17.63x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 1.05
Assets	SEK 26.6B
Cash	SEK 945.9M
Current Assets	SEK 5.6B
Current Liabilities	SEK 7.5B
Debt	SEK 15.6B
Debt EBITDA	SEK 3.86
Debt Equity	SEK 2.51
Debt FCF	SEK 8.22
Equity	SEK 6.2B
Interest Coverage	2.56
Liabilities	SEK 20.4B
Long Term Assets	SEK 21B
Long Term Liabilities	SEK 12.9B
Net Cash	SEK -14.6B
Net Cash By Market Cap	SEK -47.79
Net Debt EBITDA	SEK 4.94
Net Debt Equity	SEK 2.36
Net Debt FCF	SEK 7.72
Tangible Book Value	SEK -3B
Tangible Book Value Per Share	SEK -19.69
WACC	9.45

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.74
Inventory Turnover	28.98
Net Working Capital	SEK 668.2M
Quick ratio	0.65
Working Capital	SEK -1.9B
Working Capital Turnover	SEK -204

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.58%
Dividend Growth	32.24%
Dividend Growth Years	5%
Dividend per share	SEK 2.17
Dividend Years	6
Dividend Yield	1.07%
Ex Div Date	2026-04-30
Last Dividend	SEK 2.17
Payout Frequency	Annual
Payout Ratio	28.3%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-14.89%
200-day SMA	231.5
3Y total return	11.92%
50-day SMA	199.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-9.89%
All Time High	372
All Time High Change	-45.43%
All Time High Date	2021-12-30
All Time Low	57.25
All Time Low Change	254.59%
All Time Low Date	2017-09-26
ATR	7.1
Beta	1.5
Beta1y	1.09
Beta2y	0.77
Ch YTD	-7.94
High	210
High52	295
High52 Date	2025-07-24
High52ch	-31.19%
Low	203
Low52	179.4
Low52 Date	2026-03-23
Low52ch	13.16%
Ma50ch	1.62%
Price vs 200-day SMA	-12.3%
RSI	52.52
RSI Monthly	48.21
RSI Weekly	43.85
Sharpe ratio	-0.59x
Sortino ratio	-0.72
Total Return	0.49%
Tr YTD	-6.97
Tr1m	9.81%
Tr1w	0.5%
Tr3m	0.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK 1.8B
Operating Income Growth	57.13
Operating Income Growth Q	30
Operating Income Growth3 Y	47.59
Operating Income Growth5 Y	10.17
Operating margin	6.91

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	52,174,463%
Net Borrowing	755,330,014.8
Shares Insiders	11.48%
Shares Institutions	26.13%
Shares Out	150,978,518
Shares Qo Q	0.66%
Shares Yo Y	0.58%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK 1.7B
Average Volume	124,973.5x
Bv Per Share	39.78
CAPEX	SEK -1.7B
Ch1m	8.67
Ch1w	0.5
Ch1y	-15.77
Ch3m	-0.25
Ch3y	9.02
Ch5y	-13.62
Ch6m	-13.43
Change	-2.87%
Change From Open	-3.33
Close	209
Days Gap	0.48
Depreciation Amortization	1,113,975,921.1
Dollar Volume	10,246,222
Earnings Date	2026-04-29
EBIT	SEK 1.8B
EBITDA	SEK 3B
EPS	SEK 5.77
F Score	6
FCF	SEK 1.9B
FCF EV Yield	4.17x
FCF Per Share	SEK 12.57
Financing CF	-234,819,168
Fiscal Year End	December
Founded	1,995
Goodwill	7,183,786,183.8
Graham Number	73.11574
Graham Upside	-63.98
Income Tax	SEK 289.7M
Investing CF	-3,457,547,649
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	SEK 50.24
Lynch Upside	-75.25
Ma150	219.3
Ma150ch	-7.44%
Ma20	201.3
Ma20ch	0.85%
Net CF	-114,117,726
Next Earnings Date	2026-07-22
Open	210
P FCF Ratio	16.15
P OCF Ratio	8.49
Payment Date	2026-05-11
Position In Range	0
Ppne	11,133,238,376.2
Price Date	2026-05-08
Price EBITDA	SEK 10.34
Relative Volume	0.4x
Revenue	26,600,403,081x
SBC By Revenue	0.61x
Share Based Comp	161,301,017
Tax By Revenue	1.09x
Tax Rate	26.16%
Tr6m	-12.53%
Volume	50,474
Z Score	2.28

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

STO/MCOV.B dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$2.17 annual per share

Payout ratio

+28.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

5 consecutive years of growth

Total shareholder yield

+0.5%

Next ex-dividend date: 2026-04-30

Performance

STO/MCOV.B stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/MCOV.B?

Insider, institutional, and short-interest positioning.

Institutional ownership

+26.1%

Share of float held by funds and institutions

Insider ownership

+11.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.6%

Negative means the company is buying back shares.

Technical

STO/MCOV.B momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.5

Neutral momentum band

Price vs 200-day MA

-12.3%

50/200-day relationship not available

Beta (5Y)

1.50

More volatile than the market

Sharpe ratio

-0.59

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/MCOV.B

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/MCOV.B stock rating?

sto/MCOV.B is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/MCOV.B analysis?

The full report lives at /stocks/sto/MCOV.B/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/MCOV.B?

The latest report frames sto/MCOV.B around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/MCOV.B page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.